Autolus Therapeutics plc Restricted Cash
Autolus Therapeutics plc (AUTL) had Restricted Cash of $786.00 thousand as of 2020-09-30, per its 6-K filed 2020-11-05.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2020-11-05
- 2020-09-30: Restricted Cash $786.00K.
- 2020-06-30: Restricted Cash $786.00K.
- 2020-03-31: Restricted Cash $786.00K.
- 2019-09-30: Restricted Cash $681.00K.
| Period end | Restricted Cash |
|---|---|
| 2020-09-30 | $786.00K 6-K · filed 2020-11-05 |
| 2020-06-30 | $786.00K 6-K · filed 2020-08-06 |
| 2020-03-31 | $786.00K 6-K · filed 2020-05-07 |
| 2019-09-30 | $681.00K 6-K · filed 2020-11-05 |
| 2019-06-30 | $683.00K 6-K · filed 2020-08-06 |
| 2019-03-31 | $681.00K 6-K · filed 2020-05-07 |
| 2018-09-30 | $0.00 6-K · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |